Impel Pharmaceuticals to Participate in Upcoming Investor
SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage
Globe Newswire4-03-2023, 04:03
Water Mission Responding to Devastating Earthquake in Myanmar and Thailand 29-03-2025, 08:42